49 results
Page 2 of 3
8-K
EX-99.1
tm3mbqe
6 Jun 23
Departure of Directors or Certain Officers
4:08pm
8-K
EX-99.1
j9bc0r5efx
15 May 23
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
4:08pm
ARS
pekz7slsprg
28 Apr 23
Annual report to shareholders
12:00am
PRE 14A
wvdnh ltq
11 Apr 23
Preliminary proxy
5:49pm
8-K
EX-99.1
vi2v5ko1id
30 Mar 23
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:10pm
8-K
EX-99.1
0ynwv5okwj01mw
9 Nov 22
Absci Reports Third Quarter 2022 Financial Results
9:18am
8-K
EX-99.1
2k1m1jbpav p6wt
2 Nov 22
Absci Welcomes Meta Senior Executive to Board of Directors
4:06pm
8-K
EX-99.1
9gkpj54shqte
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
8-K
z328cdfjrf
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
DEF 14A
8lnpk9n xistv8
26 Apr 22
Definitive proxy
4:39pm
10-K
m2w4bnqppbdkw3o5
22 Mar 22
Annual report
5:20pm
8-K
EX-99.1
9p9b0tn b2
22 Mar 22
Absci Reports Full Year 2021 Financial and Operating Results
4:07pm
8-K
EX-99.1
kd95b5a7q kt2w
9 Nov 21
Absci Reports Third Quarter 2021 Financial and Operating Results
8:02am
10-Q
t8zebcl3hh1nu2yhxe
7 Sep 21
Quarterly report
8:48am